• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子物理化学性质的眼内注射药物眼内药代动力学预测模型。

A Prediction Model for the Intraocular Pharmacokinetics of Intravitreally Injected Drugs Based on Molecular Physicochemical Properties.

机构信息

Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Republic of Korea.

出版信息

Ophthalmic Res. 2020;63(1):41-49. doi: 10.1159/000499529. Epub 2019 May 21.

DOI:10.1159/000499529
PMID:31112980
Abstract

PURPOSE

This study was aimed at determining the intraocular pharmacokinetics based on molecular physicochemical properties in a rabbit model.

METHODS

The entire dataset was obtained from previous literature, and research articles regarding 70 molecular compounds were investigated. The intravitreal half-lives in rabbit eyeballs of 22 macromolecules and 48 micromolecules were analyzed. Multiple linear regression analysis was carried out with non-collinear independent variables (molecular weight [MW] and lipophilicity) influencing intravitreal half-lives. The best-fit equations were selected based on the correlation coefficients and goodness-of-fit statistics.

RESULTS

The best-fit models obtained from the entire dataset, macromolecules, and micromolecules suggest the correlation between molecular physicochemical properties (MW and lipophilicity) and intravitreal half-life. Exclusion of outlier molecules (amphotericin B and foscarnet) leads to a better-fit correlation. MW is the definite single factor affecting intravitreal half-lives of macromolecules (Log t1/2 = 0.148 + 0.370 Log MW, R2 = 0.769), while both MW and lipophilicity influence the intraocular pharmacokinetics of micromolecules (Log t1/2 = -1.213 + 0.762 Log MW - 0.115 Log p, R2 = 0.554).

CONCLUSION

The present study indicates that intravitreal half-life could be predicted based on molecular physicochemical properties (MW and lipophilicity). Also, increasing MW while reducing lipophilicity would be a reliable method for prolonging the intravitreal half-life of small chemical drugs, while MW is the single major determinant for large biologic drugs.

摘要

目的

本研究旨在通过兔模型确定基于分子物理化学特性的眼内药代动力学。

方法

整个数据集均来自先前的文献,对 70 种分子化合物的研究文章进行了调查。分析了 22 种大分子和 48 种小分子在兔眼球内的半衰期。用影响眼内半衰期的非共线性独立变量(分子量[MW]和脂溶性)进行多元线性回归分析。根据相关系数和拟合优度统计选择最佳拟合方程。

结果

从整个数据集、大分子和小分子获得的最佳拟合模型表明,分子物理化学特性(MW 和脂溶性)与眼内半衰期之间存在相关性。排除异常分子(两性霉素 B 和膦甲酸)会导致相关性更好。MW 是影响大分子眼内半衰期的唯一因素(Log t1/2=0.148+0.370 Log MW,R2=0.769),而 MW 和脂溶性均影响小分子的眼内药代动力学(Log t1/2=-1.213+0.762 Log MW-0.115 Log p,R2=0.554)。

结论

本研究表明,眼内半衰期可根据分子物理化学特性(MW 和脂溶性)进行预测。此外,增加 MW 同时降低脂溶性是延长小分子化学药物眼内半衰期的可靠方法,而 MW 是大分子生物药物的单一主要决定因素。

相似文献

1
A Prediction Model for the Intraocular Pharmacokinetics of Intravitreally Injected Drugs Based on Molecular Physicochemical Properties.基于分子物理化学性质的眼内注射药物眼内药代动力学预测模型。
Ophthalmic Res. 2020;63(1):41-49. doi: 10.1159/000499529. Epub 2019 May 21.
2
Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).基于药物理化性质预测玻璃体内半衰期:定量构效关系(QSPKR)。
Pharm Res. 2009 May;26(5):1236-60. doi: 10.1007/s11095-008-9728-7. Epub 2008 Oct 8.
3
Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats.眼内注射蛋白治疗药物的药代动力学:标准治疗方案的比较。
Mol Pharm. 2021 Jun 7;18(6):2208-2217. doi: 10.1021/acs.molpharmaceut.0c01218. Epub 2021 May 20.
4
Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.用半机制方程估算兔眼玻璃体内的半衰期
Pharm Res. 2017 Jan;34(1):49-57. doi: 10.1007/s11095-016-2037-7. Epub 2016 Sep 14.
5
Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.兔模型中玻璃体内血管内皮生长因子受体拮抗剂的眼内药代动力学
Eye (Lond). 2015 Apr;29(4):561-8. doi: 10.1038/eye.2014.329. Epub 2015 Jan 16.
6
Prediction of the vitreal half-life of small molecular drug-like compounds.小分子类似物药物玻璃体半衰期预测。
Pharm Res. 2012 Dec;29(12):3302-11. doi: 10.1007/s11095-012-0822-5. Epub 2012 Jul 10.
7
Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin.玻璃体内给予靶向 VEGF 和 Ang-2 的纳米抗体 BI-X 后的眼内和全身药代动力学-白蛋白延长半衰期的证据。
Exp Eye Res. 2021 Apr;205:108486. doi: 10.1016/j.exer.2021.108486. Epub 2021 Feb 8.
8
Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.三维玻璃体腔和脉络膜下腔药物注射输送模型。
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5266-5276. doi: 10.1167/iovs.17-23632.
9
Pharmacokinetics of intravitreal ranibizumab (Lucentis).玻璃体内注射雷珠单抗(Lucentis)的药代动力学。
Ophthalmology. 2007 Dec;114(12):2179-82. doi: 10.1016/j.ophtha.2007.09.012.
10
Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.眼内液药代动力学研究抗血管生成糖蛋白 Opticin。
Mol Pharm. 2020 Jul 6;17(7):2390-2397. doi: 10.1021/acs.molpharmaceut.0c00151. Epub 2020 Jun 9.

引用本文的文献

1
Magnetically Controlled Intraocular Delivery of Dexamethasone Using Silica-Coated Magnetic Nanoparticles.使用二氧化硅包覆磁性纳米颗粒进行地塞米松的磁控眼内给药。
ACS Omega. 2024 Jun 20;9(26):27888-27897. doi: 10.1021/acsomega.3c07033. eCollection 2024 Jul 2.
2
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds.眼部视网膜病变的给药系统:玻璃体内水凝胶作为缓释支架的光明未来。
Pharmaceutics. 2023 May 12;15(5):1484. doi: 10.3390/pharmaceutics15051484.
3
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment.
基于透明质酸的纳米粒递药系统用于治疗眼部后节疾病
Drug Deliv. 2023 Dec;30(1):2204206. doi: 10.1080/10717544.2023.2204206.
4
Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood-Brain and Retinal Barriers Studies.脑和视网膜类器官用于疾病建模:体外血脑和视网膜屏障研究的重要性。
Cells. 2022 Mar 25;11(7):1120. doi: 10.3390/cells11071120.
5
Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.视网膜及视网膜色素上皮-脉络膜-巩膜对三种眼科药物的通透性及相关因素
Pharmaceutics. 2021 May 4;13(5):655. doi: 10.3390/pharmaceutics13050655.
6
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives.眼部药物向视网膜的递送:当前创新与未来展望。
Pharmaceutics. 2021 Jan 15;13(1):108. doi: 10.3390/pharmaceutics13010108.
7
Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes.兔眼玻璃体内注射抗体和纳米颗粒的眼内分布和动力学。
Transl Vis Sci Technol. 2020 May 20;9(6):20. doi: 10.1167/tvst.9.6.20. eCollection 2020 May.
8
Author Response: Does the Fc Region Have a Role in the Ocular Half-Life After Intravitreal Injection?作者回复:Fc区域在玻璃体内注射后的眼内半衰期是否起作用?
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):21. doi: 10.1167/iovs.61.5.21.